14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Insider Trading

$1.23
+0 (+0%)
At Close: May 27, 2022
Date Action Amount Person Type
Jul 03, 2018 Buy 8 625 Jacob Gary S Warrants
Jul 03, 2018 Buy 15 Jacob Gary S Series C Convertible Preferred Stock
Jul 03, 2018 Buy 8 625 Cavan John T Warrants
Jul 03, 2018 Buy 15 Cavan John T Series C Convertible Preferred Stock
Jul 03, 2018 Buy 1 725 Brancaccio John P Warrants
Jul 03, 2018 Buy 3 Brancaccio John P Series C Convertible Preferred Stock
Jan 03, 2018 Buy 101 221 Cavan John T Common Stock
Jan 03, 2018 Buy 322 092 Sapirstein James Common Stock
Jan 03, 2018 Buy 100 654 Foster Robert T Common Stock
Jul 20, 2017 Buy 15 000 Cavan John T Stock Options
Jul 06, 2017 Buy 46 726 Cavan John T Common Stock
Jul 06, 2017 Buy 141 061 Sapirstein James Common Stock
Jul 06, 2017 Buy 44 082 Foster Robert T Common Stock
Jun 20, 2017 Buy 20 000 Cavan John T Common Stock
Apr 10, 2017 Buy 35 000 Howson Tamar D Stock Options
Mar 06, 2017 Buy 313 898 Sapirstein James Stock Options
Mar 03, 2017 Buy 313 898 Sapirstein James Stock Options
Dec 14, 2016 Buy 45 000 Howson Tamar D Stock Options
Oct 27, 2016 Sell 16 666 Sapirstein James Stock Options
Oct 27, 2016 Buy 16 666 Sapirstein James Common Stock
Sep 20, 2016 Buy 45 000 Adams Thomas Phd Stock Options
Aug 26, 2016 Buy 18 688 Cavan John T Stock Options
Aug 17, 2016 Buy 0 Cerrone Gabriel Common Stock
Aug 17, 2016 Buy 0 Cerrone Gabriel Common Stock
Aug 17, 2016 Buy 360 000 Cerrone Gabriel Stock Options
Jul 19, 2016 Buy 65 000 Brancaccio John P Stock Options
Jul 19, 2016 Buy 65 000 Jacob Gary S Stock Options
Jun 13, 2016 Buy 500 000 Sapirstein James Stock Options
Jun 10, 2016 Buy 100 000 Foster Robert T Stock Options
Apr 01, 2016 Buy 100 000 Cavan John T Stock Options
Feb 18, 2016 Buy 10 000 Sapirstein James Common Stock
Nov 30, 2015 Buy 500 Sapirstein James Common Stock
Nov 23, 2015 Buy 2 500 Sapirstein James Common Stock
Jun 04, 2015 Buy 150 000 Sapirstein James Stock Options
Dec 03, 2014 Buy 500 000 Sapirstein James Stock Options
Dec 03, 2014 Buy 38 759 Brancaccio John P Stock Options
Dec 03, 2014 Buy 118 638 Mcguigan Christopher Stock Options
Dec 03, 2014 Buy 420 000 Jacob Gary S Stock Options
Apr 03, 2014 Buy 15 000 Brancaccio John P Stock Options
Apr 03, 2014 Buy 20 000 Denoyer Bernard Stock Options
Mar 19, 2014 Buy 1 000 000 Sapirstein James Stock Options
Mar 19, 2014 Buy 300 000 Jacob Gary S Stock Options
Mar 12, 2014 Buy 16 596 Mcguigan Christopher Stock Options
Mar 12, 2014 Buy 21 897 Brancaccio John P Stock Options
Mar 04, 2014 Buy 4 393 Brancaccio John P Common Stock, par value $0.0001 per share
Feb 18, 2014 Buy 1 030 Denoyer Bernard Common Stock, par value $0.0001 per share
Feb 18, 2014 Buy 32 935 Jacob Gary S Common Stock, par value $0.0001 per share
Feb 18, 2014 Buy 2 015 Brancaccio John P Common Stock, par value $0.0001 per share
Feb 18, 2014 Sell 9 000 000 Synergy Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
INSIDER POWER
0
Last 49 transactions
Buy: 5 442 257 | Sell: 9 016 666 (Shares)

Based on the 49 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 5 442 257 and sold 9 016 666 CTRV shares in the last 49 trades.

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT